Ranjita Devi Moirangthem
Institut des Maladies Génétiques Imagine, National Centre for Cell Science, University of Calicut
Research areas: Medicine · Hematology · Hematopoietic Stem Cell Transplantation · T-cell and B-cell Immunology · Mesenchymal stem cell research
About
I have a passion in scientific research and would like to share my passion and excitement with others for the successful advancement of clinical applications with research interests in Cancer prevention and therapy, Immunotherapy, Stem cell therapy, Regenerative medicine with a main objective of improving human welfare.
Employment
-
Imagine Institute for Genetic Diseases Post doctoral researcher2016 - Present
Education
-
National Centre for Cell Science Ph.D in Biotechnology2009 - 2016
-
University of Calicut MSc. in Biotechnology2007 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors. Save
- Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy Save
- Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency. Save
- Microvesicles Secreted by Nitric Oxide-Primed Mesenchymal Stromal Cells Boost the Engraftment Potential of Hematopoietic Stem Cells. Save
- Generation of adult human T-cell progenitors for immunotherapeutic applications. Save
- Nitric oxide has contrasting age-dependent effects on the functionality of murine hematopoietic stem cells. Save
- AKT Signaling Prevailing in Mesenchymal Stromal Cells Modulates the Functionality of Hematopoietic Stem Cells via Intercellular Communication. Save
- Hypoxic niche-mediated regeneration of hematopoiesis in the engraftment window is dominantly affected by oxygen tension in the milieu. Save
- Role of FAK signaling in the regulation of HSC expansion. Save
- Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy Save
- Generation of gene corrected T cell progenitors from transduced human cord blood (CB) or mobilized peripheral blood (mPB) CD34 + Hematopoietic Stem and Progenitor cells (HSPCs) using immobilized Delta 4 culture system with TNFα supplementation. Save